NDC 60219-1753-01 - Sildenafil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-1753
- Requested NDC
- 60219-1753-01
- Package NDCs from labels
- 60219-1753-3, 60219-1753-1, 60219-1753-7, 60219-1753-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sildenafil - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Sildenafil - Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals NY LLC | 2026-07-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Sildenafil - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2025-02-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Tadalafil - CarePartners Pharmacy, LLC | CarePartners Pharmacy, LLC | 2019-08-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-1753-1 | Sildenafil | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 12 | |
| 60219-1753-3 | Sildenafil | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 12 | |
| 60219-1753-7 | Sildenafil | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-1753 | SILDENAFIL TABLET, FILM COATED [AMNEAL PHARMACEUTICALS NY LLC] | 12 | Current NDC, Legacy NDC, 3 package rows | 20231128_a1c3a2a2-8cf5-41c3-9c86-54290570d916.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-1753-3 | EA - Each | 60219-1753 | 7a949024-1edd-451b-85cf-2f18ae1c672c | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sildenafil | SILDENAFIL | AvKARE | 21c83ff3-c359-3269-e063-6394a90a57ee | 2026-01-19 | Warnings, Adverse reactions | BW9B0ZE037 |
| Tadalafil | TADALAFIL | AvKARE | b96ae7f1-7d4a-a211-e053-2995a90ab6e2 | 2026-01-16 | Warnings, Adverse reactions | 402019 403957 757707 484814 742SXX0ICT |
| Tadalafil | TADALAFIL | NuCare Pharmaceutical,Inc. | 48850075-ac57-abb7-e063-6394a90a7881 | 2026-01-16 | Warnings, Adverse reactions | 757707 742SXX0ICT |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals, Inc. | 48892acb-43bb-a4d8-e063-6394a90a5d61 | 2026-01-16 | Warnings, Adverse reactions | 403957 742SXX0ICT |
| Tadalafil | TADALAFIL | Upsher-Smith Laboratories, LLC | ae801b15-0462-44af-99a4-affe3eed899a | 2026-01-16 | Warnings, Adverse reactions | 402019 403957 757707 484814 742SXX0ICT |
| Sildenafil Citrate | SILDENAFIL | Advagen Pharma Ltd | ce683bbc-a1d2-4f23-b3d1-d9333d91dc55 | 2026-01-13 | Warnings, Adverse reactions | ANDA204883 BW9B0ZE037 |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | affacb88-4af3-4ce9-961b-7fc37b169e9a | 2026-01-12 | Warnings, Adverse reactions | 402019 742SXX0ICT |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | f34e4747-28be-4ae5-ac9a-a825083b6a9b | 2026-01-12 | Warnings, Adverse reactions | 484814 742SXX0ICT |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 7e236f83-14bf-4862-91fb-74d766aef6a9 | 2026-01-12 | Warnings, Adverse reactions | 402019 742SXX0ICT |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | cf353da9-31c6-66c2-e053-2995a90a3bb0 | 2026-01-09 | Warnings, Adverse reactions | 484814 742SXX0ICT |
| SILDENAFIL | SILDENAFIL | Advagen Pharma Ltd | e671d887-2317-4c1c-9b68-e24cda3d3aef | 2026-01-07 | Warnings, Adverse reactions | 314229 312950 314228 BW9B0ZE037 |
| Sildenafil | SILDENAFIL | Northwind Health Company, LLC | fa14cb6b-0fa8-0ba0-e053-6294a90afae3 | 2026-01-01 | Warnings, Adverse reactions | BW9B0ZE037 |
| Sildenafil | SILDENAFIL | Northwind Health Company, LLC | f3089ee6-190d-4749-e053-2a95a90a15d8 | 2026-01-01 | Warnings, Adverse reactions | 314229 BW9B0ZE037 |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f3092f5a-b976-91ab-e053-2995a90a9b50 | 2026-01-01 | Warnings, Adverse reactions | 402019 742SXX0ICT |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f317fe1e-d7c4-fb8b-e053-2a95a90a5445 | 2026-01-01 | Warnings, Adverse reactions | 403957 742SXX0ICT |
| Sildenafil Citrate | SILDENAFIL | Northwind Health Company, LLC | d9ddfd2a-1961-90f9-e053-2a95a90a7f9b | 2026-01-01 | Warnings, Adverse reactions | ANDA204883 BW9B0ZE037 |
| SILDENAFIL CITRATE | SILDENAFIL | Northwind Health Company, LLC | d9de0817-cac1-4ee5-e053-2a95a90a5fa7 | 2026-01-01 | Warnings, Adverse reactions | 314229 BW9B0ZE037 |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | 0afd0728-256a-293b-e063-6394a90a3c5f | 2025-12-26 | Warnings, Adverse reactions | 402019 742SXX0ICT |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f2a132af-d75e-2ca0-e053-2a95a90a332e | 2025-12-26 | Warnings, Adverse reactions | 402019 742SXX0ICT |
| Tadalafil | TADALAFIL | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | 0ea97208-5afc-4943-b35c-ea850203a794 | 2025-12-19 | Warnings, Adverse reactions | 402019 403957 757707 484814 742SXX0ICT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.